Aliana Gonzaga-Guerrieri

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 95 publications

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia: Long-Term Results From an Individual-Participant Data Pooled Analysis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2026

Characterization of a Genetic Variant in BARD1 in Subjects Undergoing Germline Testing for Hereditary Tumors.

Characterization of a Genetic Variant in BARD1 in Subjects Undergoing Germline Testing for Hereditary Tumors.

Journal: Biomedicines

Published: October 01, 2025

Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study.

Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study.

Journal: Cancers

Published: August 04, 2025

Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer.

Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer.

Journal: Journal of the National Cancer Institute

Published: May 21, 2025

Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Journal: Cancer prevention research (Philadelphia, Pa.)

Published: April 01, 2025

Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches.

Germline Testing in Breast Cancer: A Single-Center Analysis Comparing Strengths and Challenges of Different Approaches.

Journal: Cancers

Published: February 25, 2025

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.

Journal: Genes

Published: November 27, 2024

Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.

Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 17, 2024

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

Journal: NPJ breast cancer

Published: August 09, 2024

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.

Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer.

Journal: PloS one

Published: August 05, 2024

A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.

A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.

Journal: Nutrients

Published: May 30, 2024

Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.

Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.

Journal: Journal of the National Cancer Institute

Published: April 17, 2024

Showing 1-12 of 95

Last Updated: 09/26/2026